$29.42 1.3%
HIMS Stock Price vs. AI Score
Data gathered: January 22

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

AI Stock Analysis - hims (HIMS)

Analysis generated January 17, 2025. Powered by Chat GPT.

hims is a telehealth company that provides a range of health and wellness services and products. The company focuses on men's and women's health, offering treatments for conditions like hair loss, erectile dysfunction, skin care, and mental health. hims aims to destigmatize these health issues and make healthcare more accessible to people via its online platform. The company has been experiencing notable growth, attracting a substantial customer base and expanding its product offerings.

Read full AI stock Analysis

Stock Alerts - hims (HIMS)

company logo hims | January 22
Insider Alert: Dudum Andrew is selling shares
company logo hims | January 21
Price is up by 5% in the last 24h.
company logo hims | January 17
Price is down by -5.9% in the last 24h.
company logo hims | January 15
Price is up by 5.1% in the last 24h.

About hims

Hims & Hers Health, Inc. is a telemedicine company that operates Hims and Hers, which sell men's and women's personal care products. Hims, Inc. was founded in 2017 with the launch of Hims, and Hers was launched in 2018. In January 2019, Hims became the second-fastest startup to become a so-called 'unicorn' after Bird.


hims
Price $29.42
Target Price Sign up
Volume 1,230,000
Market Cap $6.08B
Year Range $13.65 - $34.23
Dividend Yield 0%
PE Ratio 63.3
Analyst Rating 43% buy
Industry Retail

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '24402M84M318M76M23M0.320
Q2 '24316M59M257M13M12M0.060
Q1 '24278M49M229M11M11M0.050
Q4 '23247M43M204M1.2M300,0000.010
Q3 '23227M39M187M-7.6M-7.8M-0.040

Insider Transactions View All

Dudum Andrew filed to sell 27,918 shares at $27.4.
January 21 '25
Dudum Andrew filed to sell 29,018 shares at $27.
January 21 '25
Dudum Andrew filed to sell 475,330 shares at $27.3.
January 21 '25
Dudum Andrew filed to sell 30,710 shares at $27.2.
January 21 '25
Dudum Andrew filed to sell 38,463 shares at $27.
January 21 '25

What is the Market Cap of hims?

The Market Cap of hims is $6.08B.

What is hims' PE Ratio?

As of today, hims' PE (Price to Earnings) ratio is 63.3.

What is the current stock price of hims?

Currently, the price of one share of hims stock is $29.42.

How can I analyze the HIMS stock price chart for investment decisions?

The HIMS stock price chart above provides a comprehensive visual representation of hims' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling hims shares. Our platform offers an up-to-date HIMS stock price chart, along with technical data analysis and alternative data insights.

Does HIMS offer dividends to its shareholders?

As of our latest update, hims (HIMS) does not offer dividends to its shareholders. Investors interested in hims should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of hims?

Some of the similar stocks of hims are Costco, Dollar Tree, Target, Big Lots, and Macy's.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2025 AltIndex. All rights reserved.